|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Royalty | |||||
| License | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Interest and investment income, net | |||||
| Change in fair value of Series 1 nonconvertible preferred stock | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
